Leaflet RHESONATIV 750UI / ml solution for injection


Indicated for: immunosuppression

Route of administration: injectable

Substance: anti-D immunoglobulin (immunoglobulin)

ATC: J06BB01 (Antiinfectives for systemic use | Immunoglobulins | Specific immunoglobulins)

Anti-D immunoglobulin is a medication used to prevent Rh isoimmunization in Rh-negative women who have been exposed to Rh-positive blood, such as during pregnancy or childbirth. It contains antibodies that neutralize Rh-positive cells, thereby preventing the formation of antibodies against them.

The medication is administered via intramuscular or intravenous injection, according to the doctor's instructions. It is effective in preventing hemolytic complications in subsequent pregnancies.

Side effects may include pain at the injection site, fever, headache, and, in rare cases, severe allergic reactions. Close monitoring is essential during treatment.

Consult your doctor to discuss the benefits and risks of treatment with anti-D immunoglobulin. Follow the administration instructions to ensure therapy effectiveness.

General data about RHESONATIV 750UI / ml

  • Substance: anti-D immunoglobulin
  • Date of last drug list: 01-08-2019
  • Commercial code: W65902001
  • Concentration: 750UI / ml
  • Pharmaceutical form: solution for injection
  • Packing volume: 1ml
  • Product type: original
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: OCTAPHARMA AB - SUEDIA
  • Holder: OCTAPHARMA (IP) SPRL - BELGIA
  • Number: 14524/2022/01
  • Shelf life: 30 months-after packing for marketing; after the first opening a fiolei-it is used immediately

Concentrations available for anti-D immunoglobulin

  • 300mcg
  • 300mcg/2ml
  • 625UI/ml
  • 750UI/ml